Trial intelligence / Profile preview

Effects of cholestasis on probe-drug pharmacokinetics before and after biliary drainage

NL-OMON38889Withdrawn

Sponsor
Amsterdam University Medical Center
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of caffeine, warfarin, omeprazole, metoprolol and midazolam, sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in AUC for each probe drug before versus after drainage. Planned start Jul 2013; status: withdrawn.

02

Drugs

caffeinewarfarinomeprazolemetoprololmidazolam

Beyond the preview

Go deeper on NL-OMON38889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call